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Abstract: Accumulated evidence suggests that in addition to hematopoietic stem cells (HSC), bone marrow (BM) also harbors
endothelial stem cells (ESC), mesenchymal stem cells (MSC), multipotential adult progenitor cells (MAPC), pluripotent stem cells
(PCS) as well as tissue committed stem cells (TCSC) recently identified by us. In this review we discuss the similarities and differences
between these cell populations. Furthermore, we will present the hypothesis that all of these versatile BM derived stem cells are in
fact different subpopulations of TCSC. These cells accumulate in bone marrow during ontogenesis and being a mobile population
of cells are released from BM into peripheral blood after tissue injury to regenerate damaged organs. Furthermore, since BM is a
"hideout" for TCSC, their presence in preparations of bone marrow derived mononuclear cells should be considered before
experimental evidence is interpreted simply as trans-differentiation or plasticity of HSC. Finally, our observation that the number of
TCSC accumulate in the bone marrow of young animals and their numbers decrease during senescence provides a new insight into
aging and may explain why the regeneration processes becomes less effective in older individuals.
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Introduction
Early during ontogenesis the stem cell compartment is
organized in a hierarchical manner, beginning from the
population of the most primitive pluripotent stem cells
present in the inner cell mass of the blastocyst, through
multipotent stem cells identified in the early gastrula, to
the unipotent tissue committed stem cells (TCSC) that
persist in adult tissues/organs as a pool of self-renewing
cells (e.g. TCSC for epidermis, intestine, bone marrow,
liver, heart and kidney).
The concept that bone marrow (BM) may contain
heterogenous populations of stem cells was surprisingly
not taken carefully enough into consideration in several
recently reported experiments demonstrating so called
plasticity or trans-differentiation of hematopoietic stem
cells (HSC). These studies without including proper
controls to exclude this possibility often may lead to
wrong interpretations. Compelling evidence from others
and our laboratory shows that BM harbors non-hemato-
poietic TCSC in addition to HSC [2, 28, 34, 37, 38, 41,
42]. We envision that several types of TCSC accumulate
early in development in the BM where they find a
permissive environment to survive.
Furthermore, it had been hypothesized that during
development early pluripotent/multipotent embryonic-
like stem cells (PSC) could be deposited in various
organs, including BM. Thus, marrow could potentially
contain the whole spectrum of heterogenous populations
of stem cells - beginning from early PSC to TCSC. In
this review we will discuss all of these possibilities,
shedding more light on BM as a hiding place of versatile
TCSC. We will present evidence from others and our
laboratory that supports this concept and provides a
perspective on a role of BM as a source of early cells for
regeneration/tissue repair. 
Ontogenesis of bone marrow
In mammals, the fetal liver is the major hematopoietic
organ during the second trimester of gestation. Bone
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tissue at that time contains stem cells that generate
chondrocytes, osteoblasts and fibroblasts. These cells,
as widely accepted, derive from a hypothetical em-
bryonic mesenchymal stem cell (MSC) that is a
founder cell for connective tissue lineages. The MSC,
however, had not yet been purified and its existence
in an adult organism is based mainly on indirect evi-
dence from cultures of BM-derived fibroblasts. These
cultures if growing in selective media reveal the
presence of osteoblastic, chondrocytic, and smooth
muscle cells as well as adipocytes which derive from
MSC present in cultures of BM-derived fibroblasts
[18]. However, the possibility that BM may contain
instead of MSC or in addition to them separate popu-
lations of TCSC for chondrocytes, osteoblasts and
fibroblasts was not ruled out.
The rapid development/expansion of hematopoietic
tissue takes place by the end of the second trimester of
gestation when fibroblasts and osteoblasts in early bones
began to secrete α-chemokine - stromal derived factor-1
(SDF-1) that chemoattracts HSC expressing its specific
seven-transmembrane pass G-protein coupled receptor
CXCR4, from the fetal liver into BM [12, 14, 26].
Studies in mice with knock-outs of SDF-1 or CXCR4
demonstrated that the SDF-1-CXCR4 axis plays a pivo-
tal role in colonizing BM by HSC and in establishing
adult marrow hematopoiesis. BM stroma in murine em-
bryos with SDF-1 knocked out does not chemoattract
HSC from the fetal liver, and on the other hand murine
HSC with CXCR4 knocked out do not respond to an
SDF-1 gradient and thus do not colonize BM [1]. As a
result, knock-out murine embryos display defective he-
matopoiesis in BM. This shows that the SDF-1-CXCR4
axis is one of the key players in regulating homing/reten-
tion of HSC into bone marrow and the similarity of both
knock-out phenotypes suggests that SDF-1 is the only
ligand for CXCR4 and CXCR4 only binds SDF-1. 
The important message from these developmental
studies is that CXCR4 positive HSC from the fetal liver
colonize the BM microenvironment to which they are
chemoattracted by an SDF-1 gradient. At that time BM
already contains developed vessels what suggests that
endothelial TCSC (ESC) arrive first. Since ESC origin-
ate from a hemangioblast, a common precursor for both
hematopoietic and endothelial TCSC, it is likely that
hemangioblasts arrive first in BM and play a pivotal role
in establishing marrow hematopoiesis before marrow is
colonized by fetal liver-derived HSC. It is not clear,
however, if hemangioblasts persist in BM during post-
natal life. Therefore, further studies are needed to answer
if adult bone marrow harbors some early embryonic
pluripotent/multipotent stem cells (PSC) e.g., heman-
gioblasts and/or MSC. Our recent data suggest that later
on, in postnatal life, other TCSC (e.g., for muscles,
neurons, liver, heart, pancreas and kidney) in addition to
HSC and ESC accumulate gradually in bone marrow
tissue [23, 41]. These cells similarly as HSC express
CXCR4 and are chemoattracted by SDF-1 gradient. 
Bone marrow as a hiding place for CXCR4
positive cells
Compelling evidence accumulates that CXCR4 is ex-
pressed not only on HSC, but also on other types of stem
cells beginning with the population of pluripotent em-
bryonic and germ stem cells and ending with neuronal-,
muscle (satellite)-, liver (oval)-, endothelial, pancreatic-,
renal tubular epithelium-, retinal pigment epithelium-
and lung epithelium-TCSC [5, 8, 9, 27, 29, 30, 48]. We
envision that the SDF-1-CXCR4 axis plays an important
role in the developmental trafficking of these cells. In
support of this, mice with SDF-1/CXCR4 knockouts
display several defects in the development of the heart,
large vessels and central nervous system in addition to
failure of colonizing bone marrow by fetal liver-derived
HSC. Thus, defects of the SDF-1-CXCR4 axis seem to
affect the trafficking of several types of CXCR4+ TCSC
[41].
Accumulating evidence supports the role of the SDF-
1-CXCR4 axis in tumor metastasis [21]. Recent data
suggests that tumors/leukemias develop primarily from
the stem cell compartment [31, 44, 47]. Thus, the earliest
neoplastic cells, founder cells for expanding/metastasiz-
ing tumors, frequently express functional CXCR4, as do
stem cells from which these malignancies originate. This
explains why several tumors employ the SDF-1-CXCR4
axis for metastasis, and metastasize to tissues that highly
express/secrete SDF-1 (e.g., bone marrow, lymph nodes
or lungs). In support of this, CXCR4 was reported to play
a pivotal role in metastasis of breast cancer, lung cancer
and prostate cancer cells that originate as mentioned
above in CXCR4 positive breast-, bronchial- and pros-
tate-derived epithelial TCSC [7, 10, 13]. Similarly, func-
tional CXCR4 was reported to be expressed on several
pediatric sarcomas such as neuroblastoma, rhabdomyo-
sarcoma, Ewing sarcoma, Willms tumor and retinoblas-
toma that originate from CXCR4 positive stem cells for
neural, muscle, renal tubular epithelium, neuroectoder-
mal and retina pigment epithelium, respectively [7, 10,
13, 16]. The data from our and other laboratories indicate
that this particular group of tumors known as the so
called "small round blue cell tumors" frequently metastas-
ize to bone marrow in a SDF-1-CXCR4 dependent man-
ner. The involvement of BM by these sarcomas may be so
extensive that it mimics acute lymphoblastic leukemia.
Therefore, BM due to its extensive network of sinu-
soid vessels and being a source of several locally se-
creted growth factors and chemoattractants (e.g.,
SDF-1) may attract CXCR4+ cells circulating in the
peripheral blood. These CXCR4+ cells, both normal and
malignant, find in the bone marrow a friendly permissive
environment to survive/expand. 
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CXCR4 positive TCSC may circulate in
peripheral blood
It is well known that HSC circulate in peripheral blood
to maintain in balance hematopoiesis in the marrow
tissue that is spread in distant bones. The same phenome-
non was recently described for endothelial- and skele-
tal-TCSC [25, 40, 46]. Furthermore, reconstitution
experiments of damaged muscle, kidney, lung, liver,
pancreas or heart tissue strongly suggest that under some
circumstances, BM-derived TCSC egress from the mar-
row and via peripheral blood migrate into damaged
tissues. This migration is facilitated by several chemoat-
tractants secreted by the damaged organs in response to
injury. Evidence from our and other laboratories sug-
gests that the SDF-1-CXCR4 axis plays a pivotal role in
attracting these CXCR4+ TCSC [2, 17, 23, 24, 28, 34,
37, 38, 41, 42, 48].
We postulate that circulating TCSC similarly as cir-
culating HSC keep in balance a pool of stem cells in
homologous tissues that are spread in distant areas of the
body (e.g., hemato/lymphopoietic tissue, muscles or
neural tissue) [42]. TCSC circulate in peripheral blood
probably at the highest number in young individuals
during their intensive growth [23]. 
We envision that marrow-derived CXCR4+ TCSC
played a major, albeit underappreciated role in
tissue/organ regeneration studies after therapeutic infu-
sion of bone marrow-derived cells, reported in the past.
Their role in tissue repair (e.g., heart infarct, liver injury)
was probably erroneously interpreted as trans-dedif-
ferentiation or plasticity of HSC. The number of
CXCR4+ TCSC increases in peripheral blood after phar-
macological mobilization (e.g., G-CSF) or "organ in-
jury" induced mobilization (e.g., heart infarct, liver
damage) [41]. In fact, we recently detected mRNA for
liver TCSC (α-fetoprotein, CK19) and cardiac TCSC
(NskX2, GATA-4) in circulating peripheral blood
mononuclear cells of mice after toxic injury of the liver
by CCl4 or heart infarct [23, 41]. In both situations,
mRNA for markers of endothelial TCSC (e.g., VE-cad-
herin, von Willebrand factor) was also upregulated in
mononuclear cells isolated from peripheral blood. This
suggests that versatile populations of TCSC contribute
to optimal regeneration of the damaged organs. 
There are two important implications from the circu-
lation of TCSC. First, TCSC accumulate in bone marrow
tissue that provides them with a supportive environment.
Second, since stem cell niches in various organs secrete
SDF-1, circulating TCSC may compete for seeding/oc-
cupancy of these niches in peripheral tissues. This ex-
plains why in various tissue-specific niches, e.g. muscle
or neural tissue, there are always detectable versatile
circulating TCSC, e.g. HSC [38, 41, 42]. In support of
this notion, we recently demonstrated that the SDF-1-
CXCR4 axis may play a pivotal role in the "homing" of
CXCR4 positive HSC into muscle tissue, as well as is
responsible for the accumulation of CXCR4 positive
muscle TCSC in the bone marrow [38, 42]. As a result
of the circulation of TCSC, heterogenous populations of
stem cells are present in various organs. The identifica-
tion of these cells in cultures from non-purified tissue-
derived cells could be erroneously interpreted as
"lineage switch", plasticity or trans-differentation of
stem cells. 
The presence of heterogeneous populations of
stem cells in the bone marrow
We have presented above an explanation why circulat-
ing TCSC accumulate in BM. Here we will provide more
evidence that BM contains versatile populations of stem
cells. The fact that these rare cells were identified by
employing different strategies (e.g. immunoaffinity se-
lection, ex vivo expansion in cultures containing mar-
row-fibroblasts) may explain the differences in their
description and nomenclature. A brief overview on these
versatile stem cells populations is presented below.
Hematopoietic stem cells (HSC)
HSC could be envisioned as TCSC for hemato/lymho-
poiesis and they are the most numerous population of
stem cells in BM. These cells in addition to CXCR4
express CD34, CD133, CD117 and are lineage markers
negative (lin-) [11, 43]. They, however, express the
hematopoietic marker CD45 [36]. HSC generate hema-
to/lymphopoietic cells. Our interpretation is that HSC
were erroneously envisioned as a population of bone
marrow-derived "plastic" cells [20, 33].
Endothelial stem/progenitor cells (ESC) 
BM also contains a population of endothelial stem/pro-
genitor cells (ESC). These cells were demonstrated to be
able to (i) egress from the bone marrow, (ii) circulate in
peripheral blood and (iii) contribute to regeneration of
vasculature in damaged heart, pancreas, limb or lung [2].
Endothelial TCSC express CD34, VEGFR2 (KDR),
TIE2 and are CD45 negative [6]. During embryonic
development, both HSC and ESC derive from a common
precursor called a hemangioblast. The presence of these
cells in adult bone marrow is still hypothetical. 
Mesenchymal stem cells (MSC)
It is accepted that MSC are present among cultured in
vitro BM-derived fibroblasts, however, they were not
yet purified as single cells from these cultures. A popu-
lation of fibroblasts that contains putative MSC is CD34-,
CD41-, CD133- and CD45-negative, but express Stro-1,
CD-90 (Thy-1) and CD106 antigens [32]. MSC easily
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differentiate in the presence of adipocytic differentiation
media into adipocytes. Similarly, they may differentiate,
if cultured in appropriate differentiating conditions, into
osteoblasts and chondrocytes [39]. Surprisingly, it has
been reported that MSC can also differentiate in the
presence of neural differentiation medium into neural
cells [17].
Multipotent adult progenitor cells (MAPC)
This population of cells was isolated after prolonged in
vitro culture of adherent BMMNC depleted from CD45+
and Ter119+ cells plated on fibronectin covered plates
in a medium supplemented with PDGF, EGF and LIF in
the presence of a low serum concentration. These cells
were initially described as mesodermal progenitor cells
(MPC), and after it was found that they may "cross"
germ layer boundaries and differentiate not only into
bone-, cartilage- or smooth muscle cells (mesoderm),
but also into hepatocytes (endoderm) or neural cells
(ectoderm), they were renamed as multipotent adult
progenitor cells (MAPC) [18, 19, 45]. MAPC which are
CD34, CD44, CD45 and CD117 negative were found in
human, rat and murine bone marrow, as well as in
murine muscle and brain. Murine MAPC may express a
low level of Sca-1 antigen. 
Pluripotent stem cells (PSC)
These cells were very recently identified and isolated by
FACS in a so called side-population of cells [3, 4]
present in murine bone marrow and muscle tissue [15].
PSC express Sca-1 antigen but are both CD45 and c-kit
negative [15]. Muscle derived PSC were able to dif-
ferentiate into hematopoietic cells, myocytes, neuronal
cells and adipocytes when cultured for 9-14 days in vitro
in conditions promoting hematopoietic, myogenic, neur-
onal and adipocytic differentiation respectively [15].
The same group of investigators described the presence
of PSC in brain, blood and intestinal epithelium [15].
However, PCS and MAPC were isolated by different
approaches (FACS and prolonged in vitro culture from
pre-purified BMMNC, respectively) and both popula-
tions of cells are CD45 and c-kit negative. They differ,
however, in Sca-1 antigen expression that is high in PSC
and low in MAPC [15, 39]. The most striking difference
between both populations of these putative cells is the
fact that MAPC in contrast to PSC do not differentiate
in vitro along the hematopoietic lineage. 
CXCR4 positive tissue committed stem cells
(TCSC)
Our recent studies, in which we employed chemotactic
isolation to an SDF-1 gradient (Fig. 1) combined with
real time RT-PCR analysis revealed that BM contains a
population of CXCR4+ cells that expresses mRNA for
various markers of early tissue-committed stem/pro-
genitor cells for skeletal muscle (Myf-5, Myo-D),
myocardium (Nkx2.5, GATA-4, Mef2C), neural
(GFAP, nestin), endothelial (VE-cadherin, vonWille-
brand), pancreas (Nkx6.1, Pdx1, Ptf1) and liver (CK19,
fetoprotein) (Fig. 2). These cells are present in bone
marrow and could be purified by chemotaxis to SDF-1
or enriched after staining with anti-CXCR4 antibodies
by FACS. Our recent phenotyping studies revealed that
these cells are CXCR4+ CD34+ AC133+ CD45- in hu-
mans and CXCR4+ Sca-1+ c-kit+ CD45- in mice [23, 24,
41]. We envision that TCSC is a prevalent fraction of
non-hematopoietic stem cells that reside in the bone mar-
row and we will below provide our interpretation that these
cells historically detected by different experimental
strategies were described as MSC, MAPC or PSC.
Relations of CXCR4+ TCSC to other bone
marrow stem cells
According to these data we have postulated that the BM
is not only a home for HSC but also a "hideout" for
already differentiated non-hematopoietic CXCR4+
TCSC [41]. Our view on relations of CXCR4+ TCSC to
other bone marrow stem cells is presented below. 
Relation to HSC 
TCSC described by us could be further purified from
HSC by employing CD45 antigen as a selection marker.
We found that TCSC for non-hematopoietic tissues are
CD45 negative in contrast to HSC (TCSC for the hema-
topoietic lineage) which are CD45 positive. In support
of this, murine CXCR4+ Sca-1+ CD45- cells, that are
highly enriched in TCSC did not produce any colonies
in vitro and did not form spleen colonies (CFU-S) after
transplantation into lethally irradiated animals. In con-
trast, hematopoietic colonies in vitro as well as CFU-S
were formed by murine CXCR4+ Sca-1+ CD45+ cells.
Thus, a population of murine CXCR4+ Sca-1+ cells
contains both hematopoietic (HSC) and non-hemato-
poietic TCSC which could be separated by isolating
CD45+ and CD45- cells, respectively.
Relation to MSC and MAPC
Since in humans TCSC are enriched in a population of
non-adherent CXCR4+ CD34+ AC133+ BMMNC, these
cells are different from MSC which are a population of
adherent CXCR4- CD34- cells. Furthermore, since
TCSC are CXCR4+ CD34+, they are also different from
MAPC which do not express either marker. The possi-
bility that TCSC may "contaminate" cultures of bone
marrow-derived adherent MSC and MAPC will be dis-
cussed later. 
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Relation to PSC
The population of murine TCSC show a very similar
phenotype (Sca-1+, CD45-) to murine PSC [15]. There
are, however, some significant differences. For
example, by employing a sensitive real time RT-PCR as
well as immunostaining we noticed that several tissue-
committed markers, e.g., for skeletal muscle, heart
muscle, liver, neural tissue and endothelium are already
expressed in TCSC freshly isolated from bone marrow
[41]. In contrast, PCS were reported to acquire the
expression of these markers first after several days of
culture in vitro [15]. Moreover, murine TCSC in contrast
to murine PSC express c-kit [15]. These differences,
however, do not preclude that among purified TCSC we
may still have a rare population of PCS that are founder
cells for more differentiated TCSC. In fact, we detected
in purified CXCR4+ TCSC the expression of mRNA for
early embryonic transcription factors such as Oct-4,
Rev-1 and Nanog (manuscript in preparation). However,
it is also possible that expression of mRNA for these
genes is not restricted for PCS and could also be ex-
pressed by more differentiated TCSC [35].
Fig. 1. Chemotactic isolation of
TCSC from bone marrow. Mononu-
clear cells freshly isolated from bone
marrow are loaded into the upper
chamber of transwells and allowed
to undergo chemotaxis for 5 h to the
control medium or SDF-1 gradient.
Subsequently cells are isolated from
the control input and lower chambers
and expression of mRNA for early
muscle, neural and liver stem/pro-
genitor cell markers is evaluated by
real-time RT-PCR. Cells isolated by
chemotacic gradient may be also
stained for expression of lineage-
specific proteins (e.g., Myo-D, nes-
tin or CK19). 
Fig. 2. Age dependent real time RT-
PCR analysis of mRNA expression
for early muscle, neural and liver
markers in murine BMMNC iso-
lated by chemotaxis to SDF-1. BM
cells were isolated from the lower
transwell-chambers after chemo-
taxis to SDF-1 and expression of
mRNA for early muscle (MyoD),
neural (GFAP) and liver (CK19)
TCSC were compared between the
same number of cells from the input
and lower chamber by employing
real-time RT-PCR. The data are
pooled together from three inde-
pendent experiments (12 mice/
point). Data are expressed as means
± SD.
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TCSC, MAPC and MSC: are we looking from
different angles at the same population of stem
cells?
The presence of versatile populations of stem cells that
in addition to HSC and TCSC reside in BM raises an
important question. Are the hypothetical MAPC and
MSC in fact TCSC detected by different approaches?
The rationale for this possibility is that cultures of mar-
row-derived adherent cells used to expand MAPC and
MSC may contain some TCSC from the beginning. The
hypothetical explanation of this possibility will be
presented below.
First, the predominant cell type among cultured
MAPC and MCS is bone marrow fibroblastic cells that
secrete SDF-1. It is very likely that CXCR4+ TCSC are
co-isolated with these cells and subsequently, if plated
into cultures, survive/expand being in close contact with
fibroblasts that secrete SDF-1. It is also likely that TCSC
could be embedded inside stromal fibroblasts through a
mechanism known as emperipolesis. To further support
our hypothesis, it was recently postulated that MAPC if
plated in differentiating media may differentiate not only
into cells that were identified as direct descendants of
mesodermal MSC (osteoblasts, myocytes, chondro-
blasts and adipocytes) but also may differentiate into
cardiomyocytes and even into ectoderm-derived neural
cells or endoderm-derived hepatocytes. This, however,
occurs very rarely - raising the possibility that MAPC
cultures contain in addition to osteogenic also cardiac,
neural or hepatic TCSC that are responsible for occur-
rence of cardiomyocytes, neural cells or hepatocytes in
these cultures. We hypothesize that appearance of these
cells in the cultures was erroneously interpreted as trans-
dedifferentiation effect of MAPC. 
Second, MAPC cultures are initiated from BMMNC
CD45- and GPA-A- cells that are plated on fibronectin-
covered plates. Since TCSC are CD45- and GPA-A-ne-
gative and as we found stick to fibronectin, they will be
present in a population of cells that is plated to grow/ex-
pand MAPC. Furthermore, it is likely that the chemical
composition of the culture medium and the presence of
fibroblastic cells that secrete SDF-1 in these cultures
may promote long-term survival of TCSC in these con-
ditions. Thus, TCSC present in MAPC if transferred into
the appropriate differentiation culture conditions may
form rare colonies of e.g. skeletal muscle, neural cells
or hepatocytes. These colonies, however, are formed by
TCSC and not by "hypothetical MAPC". 
Third, a similar mechanism could be responsible for
plasticity of still hypothetical MSC. Since these cells are
expanded in very similar conditions as MAPC, the dif-
ferentiation of marrow-derived fibroblastic cells (MSC)
into osteoblasts or chondrocytes could be explained by
the expansion of skeletal TCSC that from the beginning
"contaminate" cultures of these fibroblastic cells. This
hypothesis is somehow supported by the recent obser-
vations showing that cells with properties to differentiate
into osteoblasts were detected among non-adherent cells
purified from bone [33]. Moreover, we recently found
that CXCR4+ TCSC are enriched in mRNA for early
chondrocytes and adipocytes (manuscript in prepara-
tion). This supports earlier observation that bone mar-
row contains a mobile population of circulating skeletal
TCSC [25]. These cells, if co-isolated with marrow
fibroblasts, grow as small areas of osteoblastic and
chondrocytic cells interpreted as functional evidence for
the existence of MSC.
Thus, it is very likely that we are looking from
different "keyholes" at the same population of stem cells
that are hiding in a "darkroom" of the bone marrow
environment. However, the question still remains if a
very early pluripotent stem cell, a founder cell for all of
these versatile TCSC, resides in the bone marrow. It is
possible that these cells are present in BM early in the
development, and such PSC and not "plastic" HSC were
responsible for multilineage differentiation observed
after the transplantation of single purified BM-derived
"HSC" in mice [22].  
TCSC and their potential role in regeneration
and aging
Compelling evidence accumulated that bone marrow
residing TCSC may circulate in the peripheral blood and
play a role in tissue regeneration. In our recent work, we
reported that the number of these cells is the highest in
BM from young (1-2 month-old) mice and decreases in
older animals (Fig. 2). Furthermore, our observation that
the number of these cells is the highest in BM of young
mice (1-2 months, what corresponds to teen age in
humans) and decreases with time provides a new insight
into senescence and may explain why the regeneration
process becomes less effective with advancing age [23].
Our recent data show that TCSC cells also respond
to HGF and LIF gradients in addition to an SDF-1
gradient. Since we demonstrated that not only SDF-1 but
also HGF and LIF are upregulated in damaged tissues,
we postulate that early tissue-committed CXCR4+ c-
Met+ LIF-R+ cells could be mobilized from the BM into
peripheral blood from which they are subsequently che-
moattracted to the damaged organs where they play a
role in tissue repair/regeneration [23]. We cannot ex-
clude, however, the involvement of other factors in
regulating the trafficking of these cells in addition to
SDF-1, HGF and LIF. One potential candidate is for
example VEGF that was recently identified as a strong
chemoattractant not only for ESC but also for neural
TCSC [49].
In conclusion, evidence accumulated that BM in
addition to HSC contains TCSC for different non-hema-
topoietic tissues (e.g., muscle, neural, liver, endothelial)
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(Fig. 3). These TCSC could "contaminate" cultures of
BM-derived fibroblastic cells and in differentiating
media could proliferate into various tissue specific cells
(e.g., osteoblasts, chondrocytes, myocytes, hepato-
cytes). The appearance of these cells in cultured fibro-
blastic cells is interpreted as functional evidence for the
existence of the hypothetical MAPC or MSC. Moreover,
since the BM is a "hideout" of TCSC, we suggest that
their presence in BM tissue should be considered before
experimental evidence is interpreted simply as transdif-
ferentiation or plasticity of HSC. Finally, our observa-
tion that the number of these cells is the highest in the
BM of young animals and decreases with age (Fig. 2)
provides a new insight into aging and may explain why
the regeneration process becomes less effective in older
individuals. The therapeutic application of these cells for
tissue repair is one of the important challenges of the
regenerative medicine. The near future will show if these
cells could provide an alternative therapeutic approach
to the therapy based on embryonic stem cells.
References
[ 1] Ara T, Nakamura Y, Egawa T, Sugiyama T, Abe K, Kishimoto
T, Matsui Y, Nagasawa T (2003) Impaired colonization of the
gonads by primordial germ cells in mice lacking a chemokine
stromal cell-derived factor-1 (SDF-1). Proc Natl Acad Sci USA
100: 5319-5323
[ 2] Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver
M, Kearne M, Magner M, Isner JM (1999) Bone marrow origin
of endothelial progenitor cells responsible for postnatal vascu-
logenesis in physiological and pathological neovascularization.
Circ Res 85: 221-228
[ 3] Asakura A, Rudnicki MA (2002) Side population cells from
diverse adult tissues are capable of in vitro hematopoietic dif-
ferentiation. Exp Hematol 30: 1339-1345
[ 4] Asakura A, Seale P, Girgis-Gabardo A, Rudnicki MA (2002)
Myogenic specification of side population cells in skeletal
muscle. J Cell Biol 159: 123-134
[ 5] Bagri A, Gurney T, He X, Zou YR, Littman DR, Tessier-La-
vigne M, Pleasure SJ (2002) The chemokine SDF-1 regulates
migration of dentate granule cells. Development 129: 4249-
4260
[ 6] Boyer M, Townsend L, Vogel LM, Falk J, Reitz-Vick D, Trevor
K, Villalba M, Bendick PJ, Glover JL (2000) Isolation of
endothelial cells and their progenitor cells from human periph-
eral blood. J Vasc Surg 31: 181-189
[ 7] Cooper CR, Chay CH, Gendernalik JD, Lee HL, Bhatia J,
Taichman RS, McCauley LK, Keller ET, Pienta KJ (2003)
Stromal factors involved in prostate carcinoma metastasis to
bone. Cancer 97: 739-747
[ 8] Crane IJ, Wallace CA, McKillop-Smith S, Forrester JV (2000)
CXCR4 receptor expression on human retinal pigment epithe-
lial cells from blood-retina barrier leads to chemokine secretion
and migration in response to stromal cell-derived factor 1α. J
Immunol 165 : 4372-4378
[ 9] Doitsidou M, Reichman-Fried M, Stebler J, Köprunner M,
Dörries J, Meyer D, Esguerra CV, Leung T, Raz E (2002)
Guidance of primordial germ cell migration by the chemokine
SDF-1. Cell 111: 647-659
[10] Ellis WJ, Pfitzenmaier J, Colli J, Arfman E, Lange PH, Vessella
RL (2003) Detection and isolation of prostate cancer cells from
peripheral blood and bone marrow. Urology 61: 277-281
[11] Gallacher L, Murdoch B, Wu DM, Karanu FN, Keeney M,
Bhatia M (2000) Isolation and characterization of human CD34-
Lin- and CD34+Lin- hematopoietic stem cells using cell surface
markers AC133 and CD7. Blood 95: 2813-2820
[12] Ganju RK, Brubaker SA, Meyer J, Dutt P, Yang Y, Qin S,
Newman W, Groopman JE (1998) The α-chemokine stromal
cell-derived factor-1α binds to the transmembrane G-protein-
coupled CXCR-4 receptor and activates multiple signal trans-
duction pathways. J Biol Chem 273: 23169-23175
[13] Geminder H, Sagi-Assif O, Goldberg L, Meshel T, Rechavi G,
Witz IP, Ben-Baruch A (2001) A possible role for CXCR4 and
its ligand, the CXC chemokine stromal cell-derived factor-1, in
the development of bone marrow metastasis in neuroblastoma.
J Immunol 167: 4747-4757
[14] Horuk R (2001) Chemokine receptors. Cytokine Growth Factor
Rev 12: 313-335
[15] Howell JC, Lee WH, Morrison P, Zhong J, Yoder MC, Srour
EF (2003) Pluripotent stem cells identified in multiple murine
tissues. Ann NY Acad Sci 996: 158-173
[16] Jankowski K, Kucia M, Wysoczynski M, Reca R, Zhao D,
Trzyna E, Trent J, Peiper S, Zembala M, Ratajczak J, Houghton
P, Janowska-Wieczorek A, Ratajczak MZ (2003) Both hepato-
cyte growth factor (HGF) and stromal-derived factor-1 regulate
the metastatic behavior of human rhabdomyosarcoma cells, but
only HGF enhances their resistance to radiochemotherapy.
Cancer Res 63: 7926-35
[17] Jiang Y, Henderson D, Blackstad M, Chen A, Miller RF,
Verfaillie CM (2003) Neuroectodermal differentiation from
mouse multipotent adult progenitor cells. Proc Natl Acad Sci
USA 100: 11854-11860
Fig. 3. Bone marrow as a source of versatile stem cells. Bones in
young mammals were reported to contain a population of hemato-
poietic stem cells (HSC), endothelial stem cells (ESC), mesenchymal
stem cells (MSC), multipotent adult progenitor cells (MAPC), pluri-
potent stem cells (PCS) and tissue committed stem cells (TCSC). In
aging humans, bones contain HSC (mainly located in epiphyses,
vertebrae and flat bones) and reduced number of ESC, MAPC and
MSC. We hypothesize that all these cells could be envisioned as
hematopoietic and non-hematopoietic tissue committed stem cells
(TCSC). These TCSC were identified by employing different ap-
proaches (e.g., cell purification, expansion in cultures containing
fibroblasts) and given different names (e.g, MAPC or MSC). The
existence of an early precursor of TCSC (hypothetical PSC) in adult
marrow requires further studies.
CXCR4+ tissue-committed stem cells reside in bone marrow          145
[18] Jiang Y, Jahagirdar BN, Reinhardt RL, Keene CD, Ortiz-Gon-
zalez XR, et al (2002) Pluripotency of mesenchymal stem cells
derived from adult marrow. Nature 418: 41-49
[19] Keene CD, Ortiz-Gonzalez XR, Jiang Y, Largaespada DA,
Verfaillie CM, Low WC (2003) Neural differentiation and
incorporation of bone marrow-derived multipotent adult pro-
genitor cells after single cell transplantation into blastocyst stage
mouse embryos. Cell Transplant 12: 201-213
[20] Kojima H, Fujimiya M, Matsumura K, Nakahara T, Hara M,
Chan L (2004) Extrapancreatic insulin-producing cells in
multiple organs in diabetes. Proc Natl Acad Sci USA 101:
2458-2463
[21] Koshiba T, Hosotani R, Miyamoto Y, Ida J, Tsuji S, Nakajima
S, Kawaguchi M, Kobayashi H, Doi R, Hori T, Fujii N, Imamura
M (2000) Expression of stromal cell-derived factor 1 and
CXCR4 ligand receptor system in pancreatic cancer: a possible
role for tumor progression. Clin Cancer Res 6: 3530-3535
[22] Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S,
Gardner R, Neutzel S, Sharkis SJ (2001) Multi-organ, multi-li-
neage engraftment by a single bone marrow-derived stem cell.
Cell 105:369-377
[23] Kucia M, Baran J, Reca R, Majka M, Ratajczak J, Ratajczak MZ
(2004) Tissue-committed muscle, liver and neural stem cells are
deposited in the bone marrow early in development and can be
isolated by chemotactic gradients to SDF-1, HGF or LIF: novel
insights into the so-called plasticity of bone marrow-derived
stem cells and the aging process. Lancet (in press)
[24] Kucia M, Ratajczak J, Reca R, Janowska-Wieczorek A,
Ratajczak MZ (2004) Tissue-specific muscle, neural and liver
stem/progenitor cells reside in the bone marrow, respond to an
SDF-1 gradient and are mobilized into peripheral blood during
stress and tissue injury. Blood Cells Mol Dis 32: 52-57
[25] Kuznetsov SA, Mankani MH, Gronthos S, Satomura K, Bianco
P, Gehron Robey P (2001) Circulating skeletal stem cells. J Cell
Biol 153: 1133-1139
[26] Lapidot T, Kollet O (2002) The essential roles of the chemokine
SDF-1 and its receptor CXCR4 in human stem cell homing and
repopulation of transplanted immune-deficient NOD/SCID and
NOD/SCID/B2mnull mice. Leukemia 16: 1992-2003
[27] Lazarini F, Tham TN, Casanova P, Arenzana-Seisdedos F,
Dubois-Dalcq M (2003) Role of the alpha-chemokine stromal
cell-derived factor (SDF-1) in the developing and mature central
nervous system. Glia 42: 139-148
[28] Lee VM, Stoffel M (2003) Bone marrow: an extra-pancreatic
hideout for the elusive pancreatic stem cells? J Clin Invest 111:
799-801
[29] Lu M, Grove EA, Miller RJ (2002) Abnormal development of
the hippocampal dentate gyrus in mice lacking the CXCR4
chemokine receptor. Proc Natl Acad Sci USA 99: 7090-7095
[30] Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishi-
moto T, Bronson RT, Springer TA (1998) Impaired B-lympho-
poiesis , myelopoiesis and derailed cerebellar neuron migration
in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA
95: 9448-9453
[31] Marx J (2003) Mutant stem cells may seed cancer. Science 301:
1308-1310
[32] Meirelles Lda S, Nardi NB (2003) Murine marrow-derived
mesenchymal stem cell: isolation, in vitro expansion, and char-
acterization. Br J Haematol 123: 702-711
[33] Olmsted-Davis EA, Gugala Z, Camargo F, Gannon FH, Jackson
K, Anderson Kienstra K, Shine HD, Lindsey RW, Hirschi KK,
Goodell MA, Brenner MK, Davis AR (2003) Primitive adult
hematopoietic stem cells can function as osteoblast precursors.
Proc Natl Acad Sci USA 100: 15877-15882
[34] Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa
P (2003) Bone marrow stem cells regenerate infarcted myocar-
dium. Pediatr Transplant 7: 86-88
[35] Pan GJ, Chang ZY, Scholer HR, Pei D (2002) Stem cell pluri-
potency and transcription factor Oct4. Cell Res 12: 321-329
[36] Penninger JM, Irie-Sasaki J, Sasaki T, Oliveria-dos-Santos A
(2001) CD45: a new job for an old acquaintance. Nat Immunol
2: 389-396
[37] Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK,
Murase N, Boggs SS, Greenberger JS, Goff JP (1999) Bone
marrow as a potential source of hepatic oval cells. Science 284:
1168-1170
[38] Pituch-Noworolska A, Majka M, Janowska-Wieczorek A, Baj-
Krzyworzeka A, Urbanowicz B, Malec E, Ratajczak MZ (2003)
Circulating CXCR4-positive stem/progenitor cells compete for
SDF-1-positive niches in bone marrow, muscle and neural
tissues: an alternative hypothesis to stem cell plasticity. Folia
Histochem Cytobiol 41: 13-21
[39] Qi H, Aguiar DJ, Williams SM, La Pean A, Pan W, Verfaillie
CM (2003) Identification of genes responsible for osteoblast
differentiation from human mesodermal progenitor cells. Proc
Natl Acad Sci USA 100: 3305-3310
[40] Raffi S (2000) Circulating endothelial precursors: mystery,
reality, and promise. J Clin Invest 105: 17-19
[41] Ratajczak MZ, Kucia M, Reca R, Majka M, Janowska-Wieczo-
rek A, Ratajczak J (2004) Stem cell plasticity revisited: CXCR4-
positive cells expressing mRNA for early muscle, liver and
neural cells ’hide out’ in the bone marrow. Leukemia 18: 29-40
[42] Ratajczak MZ, Majka M, Kucia M, Drukala J, Pietrzkowski Z,
Peiper S, Janowska-Wieczorek A (2003) Expression of func-
tional CXCR4 by muscle satellite cells and secretion of SDF-1
by muscle-derived fibroblasts is associated with the presence of
both muscle progenitors in bone marrow and hematopoietic
stem/progenitor cells in muscles. Stem Cells 21: 363-371
[43] Ratajczak MZ, Pletcher CH, Marlicz W, Machalinski B, Moore
J, Wasik M, Ratajczak J, Gewirtz AM (1998) CD34+, kit+,
rhodamine 123 (low) phenotype identifies a marrow population
highly enriched for human hematopoietic stem cells. Leukemia
12: 942-950
[44] Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem
cells, cancer and cancer stem cells. Nature 414: 105-111
[45] Schwartz RE, Reyes M, Koodie L, Jiang Y, Blackstad M, Lund
T, Lenvik T, Johnson S, Hu WS, Verfaillie CM (2002) Multi-
potent adult progenitor cells from bone marrow differentiate
into functional hepatocyte-like cells. J Clin Invest 109: 1291-
1302
[46] Shi Q, Raffi S, Wu MH, Wijelath ES, Yu C, Ishida A, Fujita Y,
Kothari S, Mohle R, Sauvage LR, Moore MAS, Storb RF,
Hammond WP (1998) Evidence for circulating bone marrow-
derived endothelial cells. Blood 92: 362-367
[47] Tu SM, Lin SH, Logothetis CJ (2002) Stem-cell origin of
metastasis and heterogeneity in solid tumours. Lancet Oncol 3:
508-513
[48] Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M,
Murasawa S, Boch-Marce M, Masuda H, Losorodo DW, Isner
JM, Asahara T (2003) Stromal cell derived factor-1 effects on
ex vivo expanded endothelial progenitor cell recruitment for
ischemic neovascularization. Circulation 107: 1322-1328
[49] Zhang H, Vutskits L, Pepper MS, Kiss JZ (2003) VEGF is a
chemoattractant for FGF-2-stimulated neural progenitors. J Cell
Biol 163: 1375-1384
 Accepted February 27, 2004
146 M.Z. Ratajczak et al.
